Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wan-Teck Lim

Showing results (21-30 of 157) with videos related to

Pageof 16
Sort By:
NPJ Precision Oncology|October 12, 2019
Liquid biopsy: one cell at a timeSu Bin Lim, Wen Di Lee, Jyothsna Vasudevan, et al.
Biomedicines|February 25, 2023
Circulating Biomarkers for Prediction of Immunotherapy Response in NSCLCKah Yee Goh, Terence You De Cheng, Su Chin Tham, et al.
Biomedicines|August 28, 2025
Novel Therapeutic Strategies for Squamous Cell Carcinoma of the Head and Neck: Beyond EGFR and Checkpoint BlockadeRachel Hui Zhen Sim, Pei Jye Voon, Seng Wee Cheo, et al.
Cancers|November 27, 2021
Prognostic Matrisomal Gene Panel and Its Association with Immune Cell Infiltration in Head and Neck CarcinomasYuri Belotti, Su Bin Lim, Narayanan Gopalakrishna Iyer, et al.
Oncology Reports|March 17, 2009
Assessment of human papillomavirus and Epstein-Barr virus in lung adenocarcinomaWan-Teck Lim, Khoon Leong Chuah, Swan Swan Leong, et al.
Journal of Alternative and Complementary Medicine (New York, N.Y.)|January 11, 2007
Electroacupuncture for refractory acute emesis caused by chemotherapySu-Pin Choo, Keng-He Kong, Wan-Teck Lim, et al.
Cancer Treatment Reviews|April 19, 2025
Management approaches for recurrent or metastatic head and neck squamous cell carcinoma after anti-PD-1/PD-L1 immunotherapyMakoto Tahara, Darren Wan-Teck Lim, Bhumsuk Keam, et al.
Biosensors & Bioelectronics|August 20, 2010
Versatile label free biochip for the detection of circulating tumor cells from peripheral blood in cancer patientsSwee Jin Tan, Rumkumar Lalitha Lakshmi, Pengfei Chen, et al.
Nature Medicine|October 9, 2014
Reply: the BIM deletion polymorphism cannot account for intrinsic TKI resistance of Chinese individuals with chronic myeloid leukemiaS Tiong Ong, Charles T H Chuah, Tun Kiat Ko, et al.
Clinical Pharmacokinetics|November 23, 2006
Pharmacogenetics of target genes across the warfarin pharmacological pathwaySuman Lal, Srinivasa Rao Jada, Xiaoqiang Xiang, et al.
Pageof 16

Showing results (21-30 of 157) with videos related to

Sort By:
Pageof 16
NPJ Precision Oncology|October 12, 2019
Liquid biopsy: one cell at a timeSu Bin Lim, Wen Di Lee, Jyothsna Vasudevan, et al.
Biomedicines|February 25, 2023
Circulating Biomarkers for Prediction of Immunotherapy Response in NSCLCKah Yee Goh, Terence You De Cheng, Su Chin Tham, et al.
Biomedicines|August 28, 2025
Novel Therapeutic Strategies for Squamous Cell Carcinoma of the Head and Neck: Beyond EGFR and Checkpoint BlockadeRachel Hui Zhen Sim, Pei Jye Voon, Seng Wee Cheo, et al.
Cancers|November 27, 2021
Prognostic Matrisomal Gene Panel and Its Association with Immune Cell Infiltration in Head and Neck CarcinomasYuri Belotti, Su Bin Lim, Narayanan Gopalakrishna Iyer, et al.
Oncology Reports|March 17, 2009
Assessment of human papillomavirus and Epstein-Barr virus in lung adenocarcinomaWan-Teck Lim, Khoon Leong Chuah, Swan Swan Leong, et al.
Journal of Alternative and Complementary Medicine (New York, N.Y.)|January 11, 2007
Electroacupuncture for refractory acute emesis caused by chemotherapySu-Pin Choo, Keng-He Kong, Wan-Teck Lim, et al.
Cancer Treatment Reviews|April 19, 2025
Management approaches for recurrent or metastatic head and neck squamous cell carcinoma after anti-PD-1/PD-L1 immunotherapyMakoto Tahara, Darren Wan-Teck Lim, Bhumsuk Keam, et al.
Biosensors & Bioelectronics|August 20, 2010
Versatile label free biochip for the detection of circulating tumor cells from peripheral blood in cancer patientsSwee Jin Tan, Rumkumar Lalitha Lakshmi, Pengfei Chen, et al.
Nature Medicine|October 9, 2014
Reply: the BIM deletion polymorphism cannot account for intrinsic TKI resistance of Chinese individuals with chronic myeloid leukemiaS Tiong Ong, Charles T H Chuah, Tun Kiat Ko, et al.
Clinical Pharmacokinetics|November 23, 2006
Pharmacogenetics of target genes across the warfarin pharmacological pathwaySuman Lal, Srinivasa Rao Jada, Xiaoqiang Xiang, et al.
Pageof 16